BioPharma Dive September 30, 2024
Sponsored content By Almac Clinical Services

The pharmaceutical sector faces intense competition, cost pressures, rapid technological advancements and increasing consolidation. These challenges, coupled with the rising demand for generic medicines and biologics that require significant investment in advanced manufacturing technologies, have led pharma companies to seek out streamlined, cost-effective solutions.

Clinical services organizations can help pharma companies address complex challenges related to global drug development and clinical trial solutions.

“When pharma companies partner with clinical services organizations, they gain access to deep resources and extensive expertise,” says Kevin Cheong, Clinical Operations Director APAC for Almac Group. “By partnering with a clinical services organization, pharma companies are empowered to take a holistic approach to overcoming the challenges they face.”

The fast-growing clinical services organization/CDMO market in the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry

Share This Article